Volume 11, Issue 39 (6-2004)                   RJMS 2004, 11(39): 151-157 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nobahar M, Vafaei A, Davachi F. The Effect of Iron(Oral or IV) and Erythropoietin(EPO) Prescription on Levels of Hematocrit and Transferrin Saturation Percentage in Hemodialysis Patients. RJMS 2004; 11 (39) :151-157
URL: http://rjms.iums.ac.ir/article-1-128-en.html
Abstract:   (8672 Views)
Iron deficiency anemia is one of the essential problems in hemodialysis patients and with presence of iron deficiency, EPO does not have any effect on hematocrit(HCT) level and transferrin saturation percentage(TSP). However, injection of IV iron together with EPO improves responses to anemia treatment. The aim of this study was to determine the effect of iron(oral or IV) prescription with or without EPO on HCT levels and TSP in hemodialysis patients in Semnan City. In this case-control study hemodialysis patients were assessed for three months during one year. At first, demographic data including age, sex, marriage situation and treatment time were collected and recorded. Then, drug prescription was investigated, HCT measurement was controlled monthly and TSP for three months. Investigation of data indicated that in patients who used three components(iron oral, IV and EPO) or used iron IV and EPO the levels of HCT and TSP increased significantly (P<0.05), whereas use of iron IV or iron IV and oral indicated a significant increase only in TSP(P<0.05). Also, the use of only oral iron did not have a significant effect (P>0.05). The obtained results showed that oral iron is unlikely to keep iron level in response to EPO. Therefore, patients with anemia and iron deficiency will always require intravenous iron therapy and it is better that they use three components all together.
Full-Text [PDF 240 kb]   (10973 Downloads)    
Type of Study: Research | Subject: Nephrology

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb